Calming and Sleeping in Uruguay

March 2013 | 18 pages | ID: CFEEB8E6E5FEN
Euromonitor International Ltd

Abstracts

Calming and sleeping is where the Ministerio de Salud Pública exerts the tightest controls and imposes the strictest sanctions. The boundary between which calming and sleeping medicines may be bought over-the-counter and those which must be sold only with a prescription is clearly determined. Psychotropic drugs used for calming and sleeping can only be acquired with special registered and numbered prescriptions issued by the Ministerio de Salud Pública, especially for each physician who...

Euromonitor International's Calming and Sleeping in Uruguay report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Calming and Sleeping market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts Globalwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Calming and Sleeping: Value 2007-2012
  Table 2 Sales of Calming and Sleeping: % Value Growth 2007-2012
  Table 3 Calming and Sleeping Company Shares 2008-2012
  Table 4 Calming and Sleeping Brand Shares 2009-2012
  Table 5 Forecast Sales of Calming and Sleeping: Value 2012-2017
  Table 6 Forecast Sales of Calming and Sleeping: % Value Growth 2012-2017
Executive Summary
Value Sales Improve the Pace
Abortion Decriminalised in 2012
Double-digit Shares Remain Out of Reach
No Changes in Distribution
Sustained Growth Rates in the Future
Key Trends and Developments
Economic Growth Begins To Slow Down
A Small and Ageing Population
Obesity and Overweight on the Rise
Merging of Small Neighbourhood Pharmacies, A Key To Survival
Market Indicators
  Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
  Table 8 Life Expectancy at Birth 2007-2012
Market Data
  Table 9 Sales of Consumer Health by Category: Value 2007-2012
  Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
  Table 11 Consumer Health Company Shares 2008-2012
  Table 12 Consumer Health Brand Shares 2009-2012
  Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
  Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
  Table 15 Forecast Sales of Consumer Health by Category: Value 2012-2017
  Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
Summary 1 Research Sources